Pyxis Oncology, Inc. (PYXS) Total Assets by Year
Pyxis Oncology, Inc. closed fiscal year 2025 with $91.5M in total assets, $38.1M in total liabilities and $53.4M in shareholder equity. This represents a decrease of 41.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Pyxis Oncology, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PYXS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $91.5M-41.8% | $157.2M-9.5% | $173.7M-17.8% | $211.4M-24.5% | $280.0M+2658.6% | $10.2M |
| Total Liabilities | $38.1M+4.6% | $36.4M-24.1% | $48.0M-5.0% | $50.6M+170.2% | $18.7M-27.5% | $25.8M |
| Total Equity | $53.4M-55.8% | $120.8M-3.9% | $125.7M-21.8% | $160.8M-38.5% | $261.3M+1770.3% | -$15.6M |
PYXS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.9M-55.4% | $64.3M-52.7% | $91.5M-41.8% | $105.6M-45.9% | $123.2M-40.9% | $135.9M-38.3% | $157.2M-9.5% | $195.3M+4.6% | $208.4M+18.9% | $220.2M+20.5% | $173.7M-17.8% | $186.7M-16.6% |
| Total Liabilities | $43.5M+22.2% | $33.0M+0.8% | $38.1M+4.6% | $36.8M-11.5% | $35.6M-7.8% | $32.8M-9.2% | $36.4M-24.1% | $41.6M-14.6% | $38.6M+28.8% | $36.1M+17.7% | $48.0M-5.0% | $48.7M+38.7% |
| Total Equity | $11.4M-86.9% | $31.3M-69.7% | $53.4M-55.8% | $68.8M-55.2% | $87.6M-48.4% | $103.1M-44.0% | $120.8M-3.9% | $153.7M+11.4% | $169.8M+16.9% | $184.2M+21.0% | $125.7M-21.8% | $137.9M-26.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Pyxis Oncology, Inc. financials
Frequently Asked Questions
What was Pyxis Oncology, Inc.'s total assets in fiscal year 2025?
Pyxis Oncology, Inc. closed fiscal year 2025 with $91.5M in total assets, $38.1M in total liabilities and $53.4M in shareholder equity.
How fast is Pyxis Oncology, Inc.'s total assets growing?
Pyxis Oncology, Inc. (PYXS) total assets fell by 41.8% year over year, from $157.2M to $91.5M in fiscal year 2025.
How has Pyxis Oncology, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Pyxis Oncology, Inc. (PYXS) total assets went from $10.2M in fiscal year 2020 to $91.5M in fiscal year 2025.
What was Pyxis Oncology, Inc.'s total assets in the most recent quarter?
Pyxis Oncology, Inc. (PYXS) reported $54.9M in total assets in Q2 2026. This represents a decrease of 55.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Pyxis Oncology, Inc. (PYXS) reported on that line in every period on record.